The evolution of systolic blood pressure as a strong predictor of cardiovascular risk and the effectiveness of fixed-dose ARB/CCB combinations in lowering levels of this preferential target.

Heritabilities, proportions of heritabilities explained by GWAS findings, and implications of cross-phenotype effects on PR interval. Hum Genet (2015) 0.77

Marketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists' arsenal. Ther Clin Risk Manag (2015) 0.75

Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease. Chin Med J (Engl) (2016) 0.75

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37

Adherence to medication. N Engl J Med (2005) 39.77

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet (1990) 25.12

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med (1997) 19.14

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet (2007) 14.96

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA (1991) 14.36

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet (2003) 12.67

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens (2003) 12.49

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ (2000) 10.66

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet (1997) 9.18

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet (2005) 9.00

Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet (2001) 6.05

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) (2002) 6.03

Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med (2001) 6.00

Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med (2006) 5.18

Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol (1971) 4.90

Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med (1993) 4.59

Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med (2007) 4.20

Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004. Arch Intern Med (2007) 3.30

Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet (2000) 3.25

Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension (2001) 3.16

Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003. J Hypertens (2003) 2.71

Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension. J Hypertens (2007) 2.01

Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations. J Am Soc Nephrol (2005) 1.96

Evidence based management of hypertension. Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review. BMJ (2001) 1.85

Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens (1998) 1.83

Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community. Hypertension (2000) 1.70

The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study. Clin Ther (2008) 1.69

Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss. Stroke (2005) 1.51

Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction. Hypertension (2007) 1.48

Diastolic blood pressure and mortality in the elderly with cardiovascular disease. Hypertension (2007) 1.45

Hypertension treatment in a medicare population: adherence and systolic blood pressure control. Clin Ther (2007) 1.31

Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin Ther (2007) 1.28

Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial. Hypertension (2001) 1.26

Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens (2002) 1.25

The greying world: a challenge for the twenty-first century. Sci Prog (2000) 1.24

The paradigm has shifted to systolic blood pressure. J Hum Hypertens (2004) 1.19

Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence? Curr Hypertens Rep (2000) 1.11

Excess morbidity and cost of failure to achieve targets for blood pressure control in Europe. Blood Press (2002) 1.03

Should diastolic and systolic blood pressure be considered for cardiovascular risk evaluation: a study in middle-aged men and women. J Am Coll Cardiol (2001) 1.02

Association of antihypertensive therapy and diastolic hypotension in chronic kidney disease. Hypertension (2007) 1.02

Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints. J Hypertens (2006) 0.97

Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Clin Ther (2007) 0.93

Efficacy and safety of irbesartan/HCTZ combination therapy as initial treatment for rapid control of severe hypertension. J Clin Hypertens (Greenwich) (2006) 0.91

Goal-oriented hypertension management: translating clinical trials to practice. Hypertension (2002) 0.90

Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Clin Ther (2005) 0.89

Aliskiren: a review of its use in the management of hypertension. Drugs (2007) 0.87

Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population. J Hypertens (2003) 0.85

Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension. Am J Hypertens (2004) 0.85

Prevalence, pathophysiology and treatment of isolated systolic hypertension in the elderly. Expert Rev Cardiovasc Ther (2004) 0.85

Is fixed combination therapy appropriate for initial hypertension treatment? Curr Hypertens Rep (2002) 0.84

Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial. Clin Ther (2005) 0.83

HYDRA: possible determinants of unsatisfactory hypertension control in German primary care patients. Blood Press (2004) 0.83

Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR): preliminary analysis of 6-month data from > 10,000 patients and review of the literature. Curr Med Res Opin (2007) 0.82

Stroke risk in systolic and combined systolic and diastolic hypertension determined using ambulatory blood pressure. The Ohasama study. Am J Hypertens (2007) 0.82

Current clinical practice in hypertension: the EISBERG (Evaluation and Interventions for Systolic Blood pressure Elevation-Regional and Global) project. Am Heart J (1999) 0.80

Is there a preferred antihypertensive therapy for isolated systolic hypertension and reduced arterial compliance? Curr Hypertens Rep (2000) 0.78

Targeting systolic blood pressure: the key to controlling combined systolic/diastolic hypertension. Am J Hypertens (2006) 0.78

Diastolic pressure in type 2 diabetes: can target systolic pressure be reached without "diastolic hypotension"? Diabetes Care (2008) 0.77

Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes. J Hypertens (2008) 0.77

Trials in isolated systolic hypertension: an update. Curr Cardiol Rep (2003) 0.76

Blood pressure normalization in a large population of hypertensive patients treated with perindopril/indapamide combination: results of the OPTIMAX trial. Vasc Health Risk Manag (2007) 0.76